Latest Healthcare Research Reports

Tag: predictive genetic testing and consumer genomics market trends

  • Predictive Genetic Testing And Consumer Genomics Market Analysis Reflecting Expansion Trends And Industry Performance

    Predictive Genetic Testing And Consumer Genomics Market Analysis Reflecting Expansion Trends And Industry Performance

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Market Size Is Forecasted For The Predictive Genetic Testing And Consumer Genomics Market By 2030 Based On Its 2026 Value?

    The predictive genetic testing and consumer genomics market has experienced rapid growth in recent years. It is anticipated to expand from $9.07 billion in 2025 to $10.49 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 15.7%. This historical growth can be linked to factors such as increasing consumer health awareness, broader accessibility of genetic testing, the growing availability of affordable sequencing technologies, rising interest in ancestry testing, and the advancement of digital health ecosystems.

    The predictive genetic testing and consumer genomics market is anticipated to expand significantly over the coming years, reaching a valuation of $18.61 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.4%. This projected expansion is driven by several factors, including a heightened demand for tailored preventive healthcare, an increase in pharmacogenomic testing, the broadening of consumer genomics platforms, greater integration with digital health applications, and stricter regulatory control over genetic data utilization. Key trends during this period are expected to encompass wider acceptance of direct-to-consumer genetic testing, increased utilization of digital health platforms, a growing desire for insights into preventive health, the proliferation of at-home sample collection kits, and a strengthened emphasis on data privacy and security.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25884&type=smp

    Which Core Factors Are Supporting The Expansion Of The Predictive Genetic Testing And Consumer Genomics Market?

    The growing understanding of personalized medicine is set to propel the expansion of the predictive genetic testing and consumer genomics market moving forward. Personalized medicine describes a healthcare approach that tailors treatment and prevention strategies based on an individual’s genetic makeup, lifestyle, and environmental elements. Awareness regarding personalized medicine is increasing because it enhances treatment effectiveness by matching therapies to a patient’s specific biological characteristics. Predictive genetic testing and consumer genomics contribute to personalized medicine by identifying genetic risks and traits, which allows for customized prevention, early detection, and treatment plans based on an individual’s genetic profile. For instance, in February 2024, the Personalized Medicine Coalition, a US-based professional membership organization, reported that the Food and Drug Administration (FDA) approved 16 new personalized medicines in 2023, marking a rise from 6 in 2022. Therefore, the expanding awareness about personalized medicine is boosting the growth of the predictive genetic testing and consumer genomics market.

    What Are The Core Segment Classifications In The Predictive Genetic Testing And Consumer Genomics Market?

    The predictive genetic testing and consumer genomics market covered in this report is segmented –

    1) By Testing Type: Diagnostic Testing, Predictive Testing, Pharmacogenomic Testing, Carrier Screening

    2) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray Technology, DNA Sequencing

    3) By Service Type: Genetic Counseling Services, Sample Collection And Analysis, Data Interpretation And Reporting

    4) By Application: Breast And Ovarian Cancer, Cardiovascular Screening, Diabetic Screening And Monitoring, Colon Cancer, Parkinsonism Or Alzheimer’s Disease, Urologic Screening Or Prostate Cancer Screening, Orthopedic And Musculoskeletal, Other Cancer Screening, Other Diseases

    5) By End User: Healthcare Providers, Research Institutions, Diagnostic Laboratories, Consumers (Direct-to-Consumer Testing)

    Subsegments:

    1) By Diagnostic Testing: Cancer Diagnostic Testing, Neurological Disorder Testing, Rare Disease Diagnostics

    2) By Predictive Testing: Cancer Risk Prediction, Cardiovascular Disease Risk, Neurodegenerative Disorder Risk

    3) By Pharmacogenomic Testing: Adverse Drug Reaction Prediction, Psychiatric Medication Response, Dosage Optimization

    4) By Carrier Screening: Cystic Fibrosis Carrier Screening, Sickle Cell Anemia Carrier Screening, Tay-Sachs Carrier Screening

    Which Trends Are Guiding The Development Of The Predictive Genetic Testing And Consumer Genomics Market?

    Leading companies operating in the predictive genetic counselling market are prioritizing the development of advanced solutions, such as the predictive genetic testing service, for the early detection of disease risk and to support informed clinical decision-making. The predictive genetic testing service is defined as a medical offering that examines an individual’s DNA to identify genetic variations linked to an elevated risk of developing specific inherited conditions or diseases in the future. For example, in August 2024, Genetic Technologies Limited, an Australia-based company that provides genomics-based health testing, launched the geneType Risk Assessment test. This test is a unique, comprehensive, multi-risk predictive genetic screening tool designed to assess an individual’s likelihood of developing serious conditions such as breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease, and type 2 diabetes. It combines clinically validated polygenic risk scores with non-genetic factors like age, family history, and clinical measurements to produce a personalized, actionable risk profile. It is engineered for proactive health management and additionally offers clear reports with tailored recommendations to guide preventive care and lifestyle choices in over 42 countries.

    Who Are The Companies Shaping The Predictive Genetic Testing And Consumer Genomics Market Landscape?

    Major companies operating in the predictive genetic testing and consumer genomics market are Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, QIAGEN N.V., Ancestry.com, Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, 23andMe Inc., Helix Inc., Color Health Inc., Mapmygenome India Ltd., Reliance Life Sciences, Dante Labs Inc., EasyDNA, Gene by Gene Ltd., Nebula Genomics Inc., Pathway Genomics Corporation

    Access The Complete Predictive Genetic Testing And Consumer Genomics Market Report:

    https://www.thebusinessresearchcompany.com/report/predictive-genetic-testing-and-consumer-genomics-global-market-report

    Which Regional Market Leads The Predictive Genetic Testing And Consumer Genomics Market?

    North America was the largest region in the predictive genetic testing and consumer genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive genetic testing and consumer genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access Predictive Genetic Testing And Consumer Genomics Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/customise?id=25884&type=smp

    Browse Through More Reports Similar to the Global Predictive Genetic Testing And Consumer Genomics Market 2026, By The Business Research Company

    Property Management Software Market 2026

    https://www.thebusinessresearchcompany.com/report/property-management-software-market

    Property Management Service Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/property-management-service-global-market-report

    Commercial Property Insurance Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/commercial-property-insurance-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Predictive Genetic Testing and Consumer Genomics Market Growth Trends and Forecast Through 2030

    Predictive Genetic Testing and Consumer Genomics Market Growth Trends and Forecast Through 2030

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    How Will The Market Value Of The Predictive Genetic Testing And Consumer Genomics Market Progress Between 2026 And 2030?

    The predictive genetic testing and consumer genomics market size has experienced significant growth in recent years. It is projected to expand from $9.07 billion in 2025 to $10.49 billion in 2026, reflecting a compound annual growth rate (CAGR) of 15.7%. The historical expansion of this market can be attributed to factors such as increased consumer health awareness, wider accessibility of genetic testing, the growing availability of affordable sequencing technologies, heightened interest in ancestry testing, and the ongoing development of digital health ecosystems.

    The predictive genetic testing and consumer genomics market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $18.61 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 15.4%. The drivers for this growth during the forecast period encompass a heightened need for tailored preventive healthcare, greater uptake of pharmacogenomic testing, the widening scope of consumer genomics platforms, deeper integration with digital health applications, and enhanced regulatory supervision over genetic data utilization. Key trends anticipated in the forecast period include the growing popularity of direct-to-consumer genetic testing, an uptick in the use of digital health platforms, an increasing desire for proactive health information, the proliferation of at-home sample collection solutions, and a stronger emphasis on data privacy and security.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25884&type=smp

    What Leading Drivers Are Supporting The Predictive Genetic Testing And Consumer Genomics Market Expansion?

    The increasing recognition of personalized medicine is set to boost the expansion of the predictive genetic testing and consumer genomics market in the future. Personalized medicine defines a medical strategy that customizes treatment and prevention approaches based on an individual’s genetic profile, lifestyle, and environmental factors. The awareness regarding personalized medicine is expanding because it enhances treatment effectiveness by aligning therapies with a patient’s distinct biological characteristics. Predictive genetic testing and consumer genomics assist personalized medicine by pinpointing genetic risks and traits, which allows for customized prevention, early diagnosis, and treatment plans tailored to an individual’s genetic profile. For instance, in February 2024, the Personalized Medicine Coalition, a US-based professional membership organization, reported that the Food and Drug Administration (FDA) approved 16 new personalized medicines in 2023, an increase from 6 in 2022. Thus, the growing understanding of personalized medicine is propelling the growth of the predictive genetic testing and consumer genomics market.

    How Is Segmentation Applied In The Predictive Genetic Testing And Consumer Genomics Market Segment Analysis?

    The predictive genetic testing and consumer genomics market covered in this report is segmented –

    1) By Testing Type: Diagnostic Testing, Predictive Testing, Pharmacogenomic Testing, Carrier Screening

    2) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray Technology, DNA Sequencing

    3) By Service Type: Genetic Counseling Services, Sample Collection And Analysis, Data Interpretation And Reporting

    4) By Application: Breast And Ovarian Cancer, Cardiovascular Screening, Diabetic Screening And Monitoring, Colon Cancer, Parkinsonism Or Alzheimer’s Disease, Urologic Screening Or Prostate Cancer Screening, Orthopedic And Musculoskeletal, Other Cancer Screening, Other Diseases

    5) By End User: Healthcare Providers, Research Institutions, Diagnostic Laboratories, Consumers (Direct-to-Consumer Testing)

    Subsegments:

    1) By Diagnostic Testing: Cancer Diagnostic Testing, Neurological Disorder Testing, Rare Disease Diagnostics

    2) By Predictive Testing: Cancer Risk Prediction, Cardiovascular Disease Risk, Neurodegenerative Disorder Risk

    3) By Pharmacogenomic Testing: Adverse Drug Reaction Prediction, Psychiatric Medication Response, Dosage Optimization

    4) By Carrier Screening: Cystic Fibrosis Carrier Screening, Sickle Cell Anemia Carrier Screening, Tay-Sachs Carrier Screening

    What Emerging Trends Are Seen In The Predictive Genetic Testing And Consumer Genomics Market?

    Within the predictive genetic testing and consumer genomics market, leading companies are prioritizing technological advancements, specifically high-throughput and cost-efficient sequencing, to facilitate extensive, precise, and economical genomic analysis. This type of sequencing involves rapidly processing a large volume of genomes while simultaneously lowering the cost per genome, thereby enabling population-wide testing. An example is Ultima Genomics Inc., a U.S.-based sequencing firm, which introduced its UG 100 sequencing system alongside ppmSeq extreme-accuracy mode in February 2024. This system delivers up to 6–8 billion reads per wafer, with dual-wafer operations achieving approximately 4.8 Tb and anticipated run durations under 14 hours. Featuring a wafer-based substrate and adaptable reagent cartridges, the system is designed to advance an industry-leading ~$100-genome roadmap, supported by reagent expenses of roughly $2,000 per wafer. The ppmSeq mode provides Q60 SNV raw-read accuracy without requiring extra workflow stages. Thanks to its blend of minimal reagent cost, extensive automation, and AI-powered variant calling, the UG 100 is suitable for wide-ranging uses, including consumer genomics, population screening, clinical WGS, pharmacogenomics, and large-scale research. In summary, the platform facilitates genomic data generation that is quicker, more scalable, and more economical compared to previous NGS technologies.

    Who Are The Companies Participating In The Predictive Genetic Testing And Consumer Genomics Market Environment?

    Major companies operating in the predictive genetic testing and consumer genomics market are Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, QIAGEN N.V., Ancestry.com, Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, 23andMe Inc., Helix Inc., Color Health Inc., Mapmygenome India Ltd., Reliance Life Sciences, Dante Labs Inc., EasyDNA, Gene by Gene Ltd., Nebula Genomics Inc., Pathway Genomics Corporation

    Get The Full Predictive Genetic Testing And Consumer Genomics Market Report:

    https://www.thebusinessresearchcompany.com/report/predictive-genetic-testing-and-consumer-genomics-global-market-report

    Which Region Is The Top Contributor To The Predictive Genetic Testing And Consumer Genomics Market By Share?

    North America was the largest region in the predictive genetic testing and consumer genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive genetic testing and consumer genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Predictive Genetic Testing And Consumer Genomics Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/predictive-genetic-testing-and-consumer-genomics-global-market-report

    Browse Through More Reports Similar to the Global Predictive Genetic Testing And Consumer Genomics Market 2026, By The Business Research Company

    Property Management Software Market

    https://www.thebusinessresearchcompany.com/report/property-management-software-market

    Property Management Service Market Report

    https://www.thebusinessresearchcompany.com/report/property-management-service-global-market-report

    Commercial Property Insurance Market Report

    https://www.thebusinessresearchcompany.com/report/commercial-property-insurance-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Predictive Genetic Testing And Consumer Genomics Market Set for Strong Expansion Reaching $18.61 Billion by 2030 at 15.4% CAGR

    Global Predictive Genetic Testing And Consumer Genomics Market Set for Strong Expansion Reaching $18.61 Billion by 2030 at 15.4% CAGR

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Market Size Growth Is Projected For The Predictive Genetic Testing And Consumer Genomics Market During The Forecast Period 2026–2030?

    The predictive genetic testing and consumer genomics market has experienced substantial expansion in its size over recent years. It is anticipated to increase from $9.07 billion in 2025 to $10.49 billion in 2026, showing a compound annual growth rate (CAGR) of 15.7%. The expansion observed in the historic period can be linked to factors such as the growth of consumer health awareness, the expansion of genetic testing accessibility, the rising availability of affordable sequencing technologies, an increasing interest in ancestry testing, and the development of digital health ecosystems.

    The predictive genetic testing and consumer genomics market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach $18.61 billion, demonstrating a compound annual growth rate (CAGR) of 15.4%. This projected growth stems from several factors, including a heightened demand for personalized preventive healthcare, the increasing uptake of pharmacogenomic testing, the broadening reach of consumer genomics platforms, greater integration with digital health applications, and enhanced regulatory scrutiny concerning genetic data utilization. Key trends expected during this period involve the rising popularity of direct-to-consumer genetic testing, wider utilization of digital health platforms, an increasing desire for preventive health information, the proliferation of at-home sample collection kits, and an intensified emphasis on data privacy and security.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25884&type=smp

    What Drivers Are Expected To Influence The Predictive Genetic Testing And Consumer Genomics Market During The Forecast Period?

    Increasing recognition of personalized medicine is anticipated to drive expansion in the predictive genetic testing and consumer genomics market in the future. This medical approach involves tailoring treatment and prevention plans for individuals, considering their unique genetic makeup, lifestyle choices, and environmental influences. Awareness of personalized medicine is expanding due to its capacity to enhance treatment efficacy through aligning therapies with a patient’s distinct biological traits. Predictive genetic testing and consumer genomics contribute to personalized medicine by identifying genetic predispositions and characteristics, thereby facilitating customized prevention, prompt diagnosis, and treatment plans congruent with an individual’s genetic profile. An example supporting this trend is seen in February 2024, when the Personalized Medicine Coalition, a US-based professional membership organization, reported that the Food and Drug Administration (FDA) had sanctioned 16 new personalized medicines in 2023, marking a rise from the 6 approved in 2022. Consequently, the heightened awareness of personalized medicine serves as a key driver for the growth of the predictive genetic testing and consumer genomics market.

    What Market Segments Are Evaluated Within The Predictive Genetic Testing And Consumer Genomics Market?

    The predictive genetic testing and consumer genomics market covered in this report is segmented –

    1) By Testing Type: Diagnostic Testing, Predictive Testing, Pharmacogenomic Testing, Carrier Screening

    2) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray Technology, DNA Sequencing

    3) By Service Type: Genetic Counseling Services, Sample Collection And Analysis, Data Interpretation And Reporting

    4) By Application: Breast And Ovarian Cancer, Cardiovascular Screening, Diabetic Screening And Monitoring, Colon Cancer, Parkinsonism Or Alzheimer’s Disease, Urologic Screening Or Prostate Cancer Screening, Orthopedic And Musculoskeletal, Other Cancer Screening, Other Diseases

    5) By End User: Healthcare Providers, Research Institutions, Diagnostic Laboratories, Consumers (Direct-to-Consumer Testing)

    Subsegments:

    1) By Diagnostic Testing: Cancer Diagnostic Testing, Neurological Disorder Testing, Rare Disease Diagnostics

    2) By Predictive Testing: Cancer Risk Prediction, Cardiovascular Disease Risk, Neurodegenerative Disorder Risk

    3) By Pharmacogenomic Testing: Adverse Drug Reaction Prediction, Psychiatric Medication Response, Dosage Optimization

    4) By Carrier Screening: Cystic Fibrosis Carrier Screening, Sickle Cell Anemia Carrier Screening, Tay-Sachs Carrier Screening

    What Key Developments And Trends Are Impacting The Predictive Genetic Testing And Consumer Genomics Market?

    Major companies operating in the predictive genetic testing and consumer genomics market are prioritizing technological advancements, such as high-throughput and cost-efficient sequencing, to facilitate large-scale, accurate, and affordable genomic analysis. High-throughput and cost-efficient sequencing refers to the ability to process a massive quantity of genomes quickly while simultaneously reducing per-genome costs, making population-level testing achievable. For instance, in February 2024, Ultima Genomics Inc., a U.S.-based sequencing company, launched its UG 100 sequencing system, featuring the ppmSeq extreme-accuracy mode, which offers up to 6–8 billion reads per wafer with dual-wafer runs reaching approximately 4.8 Tb and expected run times under 14 hours. Constructed with a wafer-based substrate and flexible reagent cartridges, the system supports an industry-leading ~$100-genome roadmap via reagent costs of roughly $2,000 per wafer. The ppmSeq mode enables Q60 SNV raw-read accuracy without the need for additional workflow steps. With its blend of low reagent cost, high automation, and AI-driven variant calling, the UG 100 is positioned for extensive applications across consumer genomics, population screening, clinical WGS, pharmacogenomics, and large-scale research. Overall, the platform delivers faster, more scalable, and more affordable genomic data generation compared to legacy NGS technologies.

    Who Are The Top Market Participants Influencing The Predictive Genetic Testing And Consumer Genomics Market?

    Major companies operating in the predictive genetic testing and consumer genomics market are Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, QIAGEN N.V., Ancestry.com, Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, 23andMe Inc., Helix Inc., Color Health Inc., Mapmygenome India Ltd., Reliance Life Sciences, Dante Labs Inc., EasyDNA, Gene by Gene Ltd., Nebula Genomics Inc., Pathway Genomics Corporation

    Read the full predictive genetic testing and consumer genomics market report here:

    https://www.thebusinessresearchcompany.com/report/predictive-genetic-testing-and-consumer-genomics-global-market-report

    Which Region Is Forecast To Lead The Predictive Genetic Testing And Consumer Genomics Market In Terms Of Market Size?

    North America was the largest region in the predictive genetic testing and consumer genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive genetic testing and consumer genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Predictive Genetic Testing And Consumer Genomics Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=25884&type=smp

    Browse Through More Reports Similar to the Global Predictive Genetic Testing And Consumer Genomics Market 2026, By The Business Research Company

    Property Management Software Market

    https://www.thebusinessresearchcompany.com/report/property-management-software-market

    Property Management Service Global Market Report

    https://www.thebusinessresearchcompany.com/report/property-management-service-global-market-report

    Commercial Property Insurance Global Market Report

    https://www.thebusinessresearchcompany.com/report/commercial-property-insurance-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Predictive Genetic Testing And Consumer Genomics Market Research: Growth Projections and Trends 2030

    Predictive Genetic Testing And Consumer Genomics Market Research: Growth Projections and Trends 2030

    Uncover key drivers, emerging technologies, and competitive movements shaping the predictive genetic testing and consumer genomics market from 2026–2035 with trusted insights from The Business Research Company

    Across 2026–2030, what is the expected market valuation path of the Predictive Genetic Testing And Consumer Genomics Market?

    The predictive genetic testing and consumer genomics market has expanded rapidly in recent years. It is projected to increase from $9.07 billion in 2025 to $10.49 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 15.7%. The historical growth of this market can be attributed to enhanced consumer health awareness, greater accessibility to genetic testing, the rising availability of affordable sequencing technologies, an increasing interest in ancestry testing, and the development of digital health ecosystems.

    The predictive genetic testing and consumer genomics market size is anticipated to experience rapid growth in the upcoming years. It is forecast to reach $18.61 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.4%. This expansion during the forecast period can be attributed to factors such as an increasing demand for personalized preventive healthcare, the rising adoption of pharmacogenomic testing, the expansion of consumer genomics platforms, growing integration with digital health apps, and increasing regulatory oversight on genetic data usage. Key trends for the forecast period include the increasing adoption of direct-to-consumer genetic testing, a rising use of digital health platforms, a growing demand for preventive health insights, the expansion of at-home sample collection kits, and an enhanced focus on data privacy and security.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25884&type=smp

    Which Drivers Are Supporting The Rise Of The Predictive Genetic Testing And Consumer Genomics Market?

    The increasing understanding of personalized medicine is anticipated to stimulate the expansion of the predictive genetic testing and consumer genomics market moving forward. Personalized medicine describes a medical approach that tailors treatment and prevention strategies based on an individual’s genetic profile, lifestyle, and environmental factors. Awareness of personalized medicine is growing because it enhances treatment effectiveness by aligning therapies with a patient’s unique biological characteristics. Predictive genetic testing and consumer genomics contribute to personalized medicine by identifying genetic risks and traits, which enables customized prevention, early diagnosis, and treatment strategies based on an individual’s genetic profile. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based professional membership organization, the Food and Drug Administration (FDA) approved 16 new personalized medicines in 2023, representing an increase from 6 in 2022. Consequently, the escalating awareness about personalized medicine is driving the growth of the predictive genetic testing and consumer genomics market.

    What Leading Segments Are Studied In The Predictive Genetic Testing And Consumer Genomics Market?

    The predictive genetic testing and consumer genomics market covered in this report is segmented –

    1) By Testing Type: Diagnostic Testing, Predictive Testing, Pharmacogenomic Testing, Carrier Screening

    2) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray Technology, DNA Sequencing

    3) By Service Type: Genetic Counseling Services, Sample Collection And Analysis, Data Interpretation And Reporting

    4) By Application: Breast And Ovarian Cancer, Cardiovascular Screening, Diabetic Screening And Monitoring, Colon Cancer, Parkinsonism Or Alzheimer’s Disease, Urologic Screening Or Prostate Cancer Screening, Orthopedic And Musculoskeletal, Other Cancer Screening, Other Diseases

    5) By End User: Healthcare Providers, Research Institutions, Diagnostic Laboratories, Consumers (Direct-to-Consumer Testing)

    Subsegments:

    1) By Diagnostic Testing: Cancer Diagnostic Testing, Neurological Disorder Testing, Rare Disease Diagnostics

    2) By Predictive Testing: Cancer Risk Prediction, Cardiovascular Disease Risk, Neurodegenerative Disorder Risk

    3) By Pharmacogenomic Testing: Adverse Drug Reaction Prediction, Psychiatric Medication Response, Dosage Optimization

    4) By Carrier Screening: Cystic Fibrosis Carrier Screening, Sickle Cell Anemia Carrier Screening, Tay-Sachs Carrier Screening

    Which Trends Are Guiding The Evolution Of The Predictive Genetic Testing And Consumer Genomics Market?

    Leading companies within the predictive genetic testing and consumer genomics market are prioritizing technological innovations, specifically high-throughput and cost-efficient sequencing, to facilitate large-scale, accurate, and affordable genomic analysis. High-throughput and cost-efficient sequencing involves rapidly processing a vast quantity of genomes at reduced per-genome costs, making population-level testing viable. For instance, in February 2024, Ultima Genomics Inc., a U.S.-based sequencing company, unveiled its UG 100 sequencing system alongside the ppmSeq extreme-accuracy mode, delivering up to 6–8 billion reads per wafer, with dual-wafer runs attaining approximately 4.8 Tb and anticipated run times under 14 hours. Constructed with a wafer-based substrate and adaptable reagent cartridges, the system supports an industry-leading ~$100-genome roadmap, leveraging reagent costs of roughly $2,000 per wafer. The ppmSeq mode allows for Q60 SNV raw-read accuracy without requiring supplementary workflow steps. Leveraging its combination of low reagent costs, extensive automation, and AI-driven variant calling, the UG 100 is suited for diverse applications in consumer genomics, population screening, clinical WGS, pharmacogenomics, and large-scale research. Ultimately, the platform provides genomic data generation that is quicker, more scalable, and more economical than older NGS technologies.

    Which Leading Companies Dominate The Predictive Genetic Testing And Consumer Genomics Market Share?

    Major companies operating in the predictive genetic testing and consumer genomics market are Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, QIAGEN N.V., Ancestry.com, Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, 23andMe Inc., Helix Inc., Color Health Inc., Mapmygenome India Ltd., Reliance Life Sciences, Dante Labs Inc., EasyDNA, Gene by Gene Ltd., Nebula Genomics Inc., Pathway Genomics Corporation

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/predictive-genetic-testing-and-consumer-genomics-global-market-report

    How Does The Predictive Genetic Testing And Consumer Genomics Market Perform Across Major Global Regions?

    North America was the largest region in the predictive genetic testing and consumer genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive genetic testing and consumer genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Predictive Genetic Testing And Consumer Genomics Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=25884&type=smp

    Browse Through More Reports Similar to the Global Predictive Genetic Testing And Consumer Genomics Market 2026, By The Business Research Company

    Genetic Testing Services Market Report 2026

    https://www.thebusinessresearchcompany.com/report/genetic-testing-services-global-market-report

    Direct To Consumer Dtc Genetic Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/direct-to-consumer-dtc-genetic-testing-global-market-report

    Genetic Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Predictive Genetic Testing And Consumer Genomics Market Research: Growth Projections and Trends 2030

    Predictive Genetic Testing And Consumer Genomics Market Research: Growth Projections and Trends 2030

    Uncover key drivers, emerging technologies, and competitive movements shaping the predictive genetic testing and consumer genomics market from 2026–2035 with trusted insights from The Business Research Company

    Across 2026–2030, what is the expected market valuation path of the Predictive Genetic Testing And Consumer Genomics Market?

    The predictive genetic testing and consumer genomics market has expanded rapidly in recent years. It is projected to increase from $9.07 billion in 2025 to $10.49 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 15.7%. The historical growth of this market can be attributed to enhanced consumer health awareness, greater accessibility to genetic testing, the rising availability of affordable sequencing technologies, an increasing interest in ancestry testing, and the development of digital health ecosystems.

    The predictive genetic testing and consumer genomics market size is anticipated to experience rapid growth in the upcoming years. It is forecast to reach $18.61 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.4%. This expansion during the forecast period can be attributed to factors such as an increasing demand for personalized preventive healthcare, the rising adoption of pharmacogenomic testing, the expansion of consumer genomics platforms, growing integration with digital health apps, and increasing regulatory oversight on genetic data usage. Key trends for the forecast period include the increasing adoption of direct-to-consumer genetic testing, a rising use of digital health platforms, a growing demand for preventive health insights, the expansion of at-home sample collection kits, and an enhanced focus on data privacy and security.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25884&type=smp

    Which Drivers Are Supporting The Rise Of The Predictive Genetic Testing And Consumer Genomics Market?

    The increasing understanding of personalized medicine is anticipated to stimulate the expansion of the predictive genetic testing and consumer genomics market moving forward. Personalized medicine describes a medical approach that tailors treatment and prevention strategies based on an individual’s genetic profile, lifestyle, and environmental factors. Awareness of personalized medicine is growing because it enhances treatment effectiveness by aligning therapies with a patient’s unique biological characteristics. Predictive genetic testing and consumer genomics contribute to personalized medicine by identifying genetic risks and traits, which enables customized prevention, early diagnosis, and treatment strategies based on an individual’s genetic profile. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based professional membership organization, the Food and Drug Administration (FDA) approved 16 new personalized medicines in 2023, representing an increase from 6 in 2022. Consequently, the escalating awareness about personalized medicine is driving the growth of the predictive genetic testing and consumer genomics market.

    What Leading Segments Are Studied In The Predictive Genetic Testing And Consumer Genomics Market?

    The predictive genetic testing and consumer genomics market covered in this report is segmented –

    1) By Testing Type: Diagnostic Testing, Predictive Testing, Pharmacogenomic Testing, Carrier Screening

    2) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray Technology, DNA Sequencing

    3) By Service Type: Genetic Counseling Services, Sample Collection And Analysis, Data Interpretation And Reporting

    4) By Application: Breast And Ovarian Cancer, Cardiovascular Screening, Diabetic Screening And Monitoring, Colon Cancer, Parkinsonism Or Alzheimer’s Disease, Urologic Screening Or Prostate Cancer Screening, Orthopedic And Musculoskeletal, Other Cancer Screening, Other Diseases

    5) By End User: Healthcare Providers, Research Institutions, Diagnostic Laboratories, Consumers (Direct-to-Consumer Testing)

    Subsegments:

    1) By Diagnostic Testing: Cancer Diagnostic Testing, Neurological Disorder Testing, Rare Disease Diagnostics

    2) By Predictive Testing: Cancer Risk Prediction, Cardiovascular Disease Risk, Neurodegenerative Disorder Risk

    3) By Pharmacogenomic Testing: Adverse Drug Reaction Prediction, Psychiatric Medication Response, Dosage Optimization

    4) By Carrier Screening: Cystic Fibrosis Carrier Screening, Sickle Cell Anemia Carrier Screening, Tay-Sachs Carrier Screening

    Which Trends Are Guiding The Evolution Of The Predictive Genetic Testing And Consumer Genomics Market?

    Leading companies within the predictive genetic testing and consumer genomics market are prioritizing technological innovations, specifically high-throughput and cost-efficient sequencing, to facilitate large-scale, accurate, and affordable genomic analysis. High-throughput and cost-efficient sequencing involves rapidly processing a vast quantity of genomes at reduced per-genome costs, making population-level testing viable. For instance, in February 2024, Ultima Genomics Inc., a U.S.-based sequencing company, unveiled its UG 100 sequencing system alongside the ppmSeq extreme-accuracy mode, delivering up to 6–8 billion reads per wafer, with dual-wafer runs attaining approximately 4.8 Tb and anticipated run times under 14 hours. Constructed with a wafer-based substrate and adaptable reagent cartridges, the system supports an industry-leading ~$100-genome roadmap, leveraging reagent costs of roughly $2,000 per wafer. The ppmSeq mode allows for Q60 SNV raw-read accuracy without requiring supplementary workflow steps. Leveraging its combination of low reagent costs, extensive automation, and AI-driven variant calling, the UG 100 is suited for diverse applications in consumer genomics, population screening, clinical WGS, pharmacogenomics, and large-scale research. Ultimately, the platform provides genomic data generation that is quicker, more scalable, and more economical than older NGS technologies.

    Which Leading Companies Dominate The Predictive Genetic Testing And Consumer Genomics Market Share?

    Major companies operating in the predictive genetic testing and consumer genomics market are Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, QIAGEN N.V., Ancestry.com, Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, 23andMe Inc., Helix Inc., Color Health Inc., Mapmygenome India Ltd., Reliance Life Sciences, Dante Labs Inc., EasyDNA, Gene by Gene Ltd., Nebula Genomics Inc., Pathway Genomics Corporation

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/predictive-genetic-testing-and-consumer-genomics-global-market-report

    How Does The Predictive Genetic Testing And Consumer Genomics Market Perform Across Major Global Regions?

    North America was the largest region in the predictive genetic testing and consumer genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive genetic testing and consumer genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Predictive Genetic Testing And Consumer Genomics Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=25884&type=smp

    Browse Through More Reports Similar to the Global Predictive Genetic Testing And Consumer Genomics Market 2026, By The Business Research Company

    Genetic Testing Services Market Report 2026

    https://www.thebusinessresearchcompany.com/report/genetic-testing-services-global-market-report

    Direct To Consumer Dtc Genetic Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/direct-to-consumer-dtc-genetic-testing-global-market-report

    Genetic Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Predictive Genetic Testing And Consumer Genomics Market Research: Growth Projections and Trends 2030

    Predictive Genetic Testing And Consumer Genomics Market Research: Growth Projections and Trends 2030

    Uncover key drivers, emerging technologies, and competitive movements shaping the predictive genetic testing and consumer genomics market from 2026–2035 with trusted insights from The Business Research Company

    Across 2026–2030, what is the expected market valuation path of the Predictive Genetic Testing And Consumer Genomics Market?

    The predictive genetic testing and consumer genomics market has expanded rapidly in recent years. It is projected to increase from $9.07 billion in 2025 to $10.49 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 15.7%. The historical growth of this market can be attributed to enhanced consumer health awareness, greater accessibility to genetic testing, the rising availability of affordable sequencing technologies, an increasing interest in ancestry testing, and the development of digital health ecosystems.

    The predictive genetic testing and consumer genomics market size is anticipated to experience rapid growth in the upcoming years. It is forecast to reach $18.61 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.4%. This expansion during the forecast period can be attributed to factors such as an increasing demand for personalized preventive healthcare, the rising adoption of pharmacogenomic testing, the expansion of consumer genomics platforms, growing integration with digital health apps, and increasing regulatory oversight on genetic data usage. Key trends for the forecast period include the increasing adoption of direct-to-consumer genetic testing, a rising use of digital health platforms, a growing demand for preventive health insights, the expansion of at-home sample collection kits, and an enhanced focus on data privacy and security.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25884&type=smp

    Which Drivers Are Supporting The Rise Of The Predictive Genetic Testing And Consumer Genomics Market?

    The increasing understanding of personalized medicine is anticipated to stimulate the expansion of the predictive genetic testing and consumer genomics market moving forward. Personalized medicine describes a medical approach that tailors treatment and prevention strategies based on an individual’s genetic profile, lifestyle, and environmental factors. Awareness of personalized medicine is growing because it enhances treatment effectiveness by aligning therapies with a patient’s unique biological characteristics. Predictive genetic testing and consumer genomics contribute to personalized medicine by identifying genetic risks and traits, which enables customized prevention, early diagnosis, and treatment strategies based on an individual’s genetic profile. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based professional membership organization, the Food and Drug Administration (FDA) approved 16 new personalized medicines in 2023, representing an increase from 6 in 2022. Consequently, the escalating awareness about personalized medicine is driving the growth of the predictive genetic testing and consumer genomics market.

    What Leading Segments Are Studied In The Predictive Genetic Testing And Consumer Genomics Market?

    The predictive genetic testing and consumer genomics market covered in this report is segmented –

    1) By Testing Type: Diagnostic Testing, Predictive Testing, Pharmacogenomic Testing, Carrier Screening

    2) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray Technology, DNA Sequencing

    3) By Service Type: Genetic Counseling Services, Sample Collection And Analysis, Data Interpretation And Reporting

    4) By Application: Breast And Ovarian Cancer, Cardiovascular Screening, Diabetic Screening And Monitoring, Colon Cancer, Parkinsonism Or Alzheimer’s Disease, Urologic Screening Or Prostate Cancer Screening, Orthopedic And Musculoskeletal, Other Cancer Screening, Other Diseases

    5) By End User: Healthcare Providers, Research Institutions, Diagnostic Laboratories, Consumers (Direct-to-Consumer Testing)

    Subsegments:

    1) By Diagnostic Testing: Cancer Diagnostic Testing, Neurological Disorder Testing, Rare Disease Diagnostics

    2) By Predictive Testing: Cancer Risk Prediction, Cardiovascular Disease Risk, Neurodegenerative Disorder Risk

    3) By Pharmacogenomic Testing: Adverse Drug Reaction Prediction, Psychiatric Medication Response, Dosage Optimization

    4) By Carrier Screening: Cystic Fibrosis Carrier Screening, Sickle Cell Anemia Carrier Screening, Tay-Sachs Carrier Screening

    Which Trends Are Guiding The Evolution Of The Predictive Genetic Testing And Consumer Genomics Market?

    Leading companies within the predictive genetic testing and consumer genomics market are prioritizing technological innovations, specifically high-throughput and cost-efficient sequencing, to facilitate large-scale, accurate, and affordable genomic analysis. High-throughput and cost-efficient sequencing involves rapidly processing a vast quantity of genomes at reduced per-genome costs, making population-level testing viable. For instance, in February 2024, Ultima Genomics Inc., a U.S.-based sequencing company, unveiled its UG 100 sequencing system alongside the ppmSeq extreme-accuracy mode, delivering up to 6–8 billion reads per wafer, with dual-wafer runs attaining approximately 4.8 Tb and anticipated run times under 14 hours. Constructed with a wafer-based substrate and adaptable reagent cartridges, the system supports an industry-leading ~$100-genome roadmap, leveraging reagent costs of roughly $2,000 per wafer. The ppmSeq mode allows for Q60 SNV raw-read accuracy without requiring supplementary workflow steps. Leveraging its combination of low reagent costs, extensive automation, and AI-driven variant calling, the UG 100 is suited for diverse applications in consumer genomics, population screening, clinical WGS, pharmacogenomics, and large-scale research. Ultimately, the platform provides genomic data generation that is quicker, more scalable, and more economical than older NGS technologies.

    Which Leading Companies Dominate The Predictive Genetic Testing And Consumer Genomics Market Share?

    Major companies operating in the predictive genetic testing and consumer genomics market are Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, QIAGEN N.V., Ancestry.com, Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, 23andMe Inc., Helix Inc., Color Health Inc., Mapmygenome India Ltd., Reliance Life Sciences, Dante Labs Inc., EasyDNA, Gene by Gene Ltd., Nebula Genomics Inc., Pathway Genomics Corporation

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/predictive-genetic-testing-and-consumer-genomics-global-market-report

    How Does The Predictive Genetic Testing And Consumer Genomics Market Perform Across Major Global Regions?

    North America was the largest region in the predictive genetic testing and consumer genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive genetic testing and consumer genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Predictive Genetic Testing And Consumer Genomics Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=25884&type=smp

    Browse Through More Reports Similar to the Global Predictive Genetic Testing And Consumer Genomics Market 2026, By The Business Research Company

    Genetic Testing Services Market Report 2026

    https://www.thebusinessresearchcompany.com/report/genetic-testing-services-global-market-report

    Direct To Consumer Dtc Genetic Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/direct-to-consumer-dtc-genetic-testing-global-market-report

    Genetic Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Predictive Genetic Testing And Consumer Genomics Industry Anticipated to Expand at 15.5% CAGR During the Forecast Period

    Predictive Genetic Testing And Consumer Genomics Industry Anticipated to Expand at 15.5% CAGR During the Forecast Period

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    #What Is The Projected Market Size Of The Predictive Genetic Testing And Consumer Genomics Market By 2029?

    The genetic testing and consumer genomics market size has observed significant expansion in recent years. Projections show that it will rise from $7.83 billion in 2024 to $9.07 billion in 2025, achieving a compound annual growth rate (CAGR) of 15.7%. This historical growth can be linked to a growing focus on early disease detection and risk assessment, increasing affordability and accessibility of genetic testing technologies, growing consumer interest in ancestry and trait analysis, increasing expansion of telehealth platforms, and rising prevalence of chronic and hereditary diseases.

    The genetic testing and consumer genomics market size is forecast to experience rapid expansion over the next few years, projected to reach $16.14 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 15.5%. This growth within the forecast timeframe can be attributed to an increasing demand for personalized healthcare and preventive medicine, the growing accessibility of direct-to-consumer genetic testing kits, a rise in the adoption of genomics for clinical decision-making, escalating investments in biotechnology and genetic research, and increased government support for genomic research and precision medicine initiatives. Significant trends expected during this period include advancements in next-generation sequencing, the integration of AI and machine learning into genetic data analysis, developments in portable and at-home testing technologies, the incorporation of genetic data with electronic health records, and innovations in microarray technology.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25884&type=smp

    Which Drivers Are Shaping The Predictive Genetic Testing And Consumer Genomics Industry’s Market Share?

    The increasing understanding of personalized medicine is anticipated to stimulate the expansion of the predictive genetic testing and consumer genomics market moving forward. Personalized medicine defines a medical methodology that customizes treatment and prevention plans based on an individual’s genetic makeup, lifestyle, and environmental factors. The awareness regarding personalized medicine is growing because it enhances treatment effectiveness by matching therapies to a patient’s specific biological characteristics. Predictive genetic testing and consumer genomics contribute to personalized medicine by identifying genetic risks and traits, thus enabling customized prevention, early diagnosis, and treatment strategies founded on an individual’s genetic profile. For instance, in February 2024, the Personalized Medicine Coalition, a US-based professional membership organization, noted that the Food and Drug Administration (FDA) approved 16 new personalized medicines in 2023, which represents an increase from 6 approvals in 2022. Therefore, the heightened awareness about personalized medicine is propelling the growth of the predictive genetic testing and consumer genomics market.

    What Are The Emerging Segments Gaining Attention In The Predictive Genetic Testing And Consumer Genomics Market?

    The predictive genetic testing and consumer genomics market covered in this report is segmented –

    1) By Testing Type: Diagnostic Testing, Predictive Testing, Pharmacogenomic Testing, Carrier Screening

    2) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray Technology, DNA Sequencing

    3) By Service Type: Genetic Counseling Services, Sample Collection And Analysis, Data Interpretation And Reporting

    4) By Application: Breast And Ovarian Cancer, Cardiovascular Screening, Diabetic Screening And Monitoring, Colon Cancer, Parkinsonism Or Alzheimer’s Disease, Urologic Screening Or Prostate Cancer Screening, Orthopedic And Musculoskeletal, Other Cancer Screening, Other Diseases

    5) By End User: Healthcare Providers, Research Institutions, Diagnostic Laboratories, Consumers (Direct-to-Consumer Testing)

    Subsegments:

    1) By Diagnostic Testing: Cancer Diagnostic Testing, Neurological Disorder Testing, Rare Disease Diagnostics

    2) By Predictive Testing: Cancer Risk Prediction, Cardiovascular Disease Risk, Neurodegenerative Disorder Risk

    3) By Pharmacogenomic Testing: Adverse Drug Reaction Prediction, Psychiatric Medication Response, Dosage Optimization

    4) By Carrier Screening: Cystic Fibrosis Carrier Screening, Sickle Cell Anemia Carrier Screening, Tay-Sachs Carrier Screening

    Which Key Trends Are Expected To Influence The Predictive Genetic Testing And Consumer Genomics Market In The Coming Years?

    Leading companies in the predictive genetic testing and consumer genomics market are concentrating on developing innovative solutions, such as consumer genomics insight services, to furnish individuals with personalized health information and facilitate the early identification of genetic risks. A consumer genomics insight service is defined as a direct-to-consumer genetic testing solution that examines an individual’s DNA to provide insights into ancestry, potential health risks, traits, and overall wellness, without the need for a medical prescription. For instance, in November 2022, Strand Life Sciences Private Limited, an India-based technology company, introduced Strand Genomic Wellness to offer individualized health insights. This allows individuals to comprehend their genetic predisposition to various diseases, thereby supporting proactive health management and preventive care using genomic information. The primary advantage lies in enabling individuals and their physicians to make informed lifestyle and medical decisions based on unique genetic profiles.

    Who Are The Major Companies Operating In The Predictive Genetic Testing And Consumer Genomics Market?

    Major companies operating in the predictive genetic testing and consumer genomics market are Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, QIAGEN N.V., Ancestry.com, Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., 23andMe Inc., Helix Inc., Color Health Inc., Mapmygenome India Ltd., Reliance Life Sciences, Dante Labs Inc., EasyDNA, Gene by Gene Ltd., Nebula Genomics Inc., Pathway Genomics Corporation.

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/predictive-genetic-testing-and-consumer-genomics-global-market-report

    How Does The Predictive Genetic Testing And Consumer Genomics Market Perform Across Key Geographic Regions?

    North America was the largest region in the predictive genetic testing and consumer genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive genetic testing and consumer genomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Version Of The Predictive Genetic Testing And Consumer Genomics Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=25884&type=smp

    Browse Through More Reports Similar to the Global Predictive Genetic Testing And Consumer Genomics Market 2025, By The Business Research Company

    Consumer Genomics Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/consumer-genomics-global-market-report

    Direct To Consumer Dtc Genetic Testing Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/direct-to-consumer-dtc-genetic-testing-global-market-report

    Genetic Testing Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • How Will The Predictive Genetic Testing And Consumer Genomics Market Expand At A CAGR Of 15.4% Through 2029?

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    How Will The Predictive Genetic Testing And Consumer Genomics Market Valuation Change Between Now And 2029?

    The market for genetic testing and consumer genomics has seen swift expansion in recent times. It is predicted to increase from a valuation of $7.83 billion in 2024 to around $9.07 billion in 2025, marking a compound annual growth rate (CAGR) of 15.7%. Factors contributing to this growth during the historical period include the heightened emphasis on early detection and risk assessment of diseases, enhanced affordability and accessibility of genetic testing procedures, a surge in consumer interest related to ancestry and trait analysis, the broadening scope of telehealth platforms, and a rising incidence of chronic and hereditary diseases.

    The market size for genetic testing and consumer genomics is projected to experience rapid expansion in the forthcoming years, growing to a staggering $16.14 billion by 2029, with a compound annual growth rate (CAGR) of 15.5%. This surge in the prediction timeframe can be linked to the rising demand for personalized healthcare and preventative medicine, the increasing availability of genetic testing kits sold directly to consumers, a growing emphasis on genomics in clinical decision-making, heightened investment in biotech and genetic research, and increased government backing of genomic research and precision medicine initiatives. Key trends expected within the forecast period range from advancements in next-generation sequencing, the integration of Artificial Intelligence and machine learning in the analysis of genetic data, progress in portable and at-home testing technology, incorporation of genetic data into electronic health records, and advancements in microarray technology.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25884&type=smp

    What Growth-Enabling Forces Are Impacting The Predictive Genetic Testing And Consumer Genomics Market?

    The increasing consciousness about personalized healthcare is anticipated to spur the expansion of the predictive genetic testing and consumer genomics market moving forward. The tailor-made healthcare approach, known as personalized medicine, modifies treatment and prevention strategies based on a person’s unique genetic makeup, lifestyle, and environment. This approach is gaining traction because it enhances the effectiveness of therapy by accounting for the individual’s specific biological attributes. Predictive genetic testing and consumer genomics contribute to personalized medicine by discovering genetic risks and inherent traits, facilitating individualized prevention, early detection, and treatment plans corresponding to the individual’s genetic information. For instance, the Personalized Medicine Coalition, a professional membership organization based in the US, stated that the Food and Drug Administration (FDA) sanctioned 16 new customized drugs in 2023 in February 2024, marking an increase from 6 in 2022. Hence, the heightened consciousness about personalized healthcare is fueling the expansion of the predictive genetic testing and consumer genomics market.

    What Are The Main Segment Classifications In The Predictive Genetic Testing And Consumer Genomics Market?

    The predictive genetic testing and consumer genomics market covered in this report is segmented –

    1) By Testing Type: Diagnostic Testing, Predictive Testing, Pharmacogenomic Testing, Carrier Screening

    2) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray Technology, DNA Sequencing

    3) By Service Type: Genetic Counseling Services, Sample Collection And Analysis, Data Interpretation And Reporting

    4) By Application: Breast And Ovarian Cancer, Cardiovascular Screening, Diabetic Screening And Monitoring, Colon Cancer, Parkinsonism Or Alzheimer’s Disease, Urologic Screening Or Prostate Cancer Screening, Orthopedic And Musculoskeletal, Other Cancer Screening, Other Diseases

    5) By End User: Healthcare Providers, Research Institutions, Diagnostic Laboratories, Consumers (Direct-to-Consumer Testing)

    Subsegments:

    1) By Diagnostic Testing: Cancer Diagnostic Testing, Neurological Disorder Testing, Rare Disease Diagnostics

    2) By Predictive Testing: Cancer Risk Prediction, Cardiovascular Disease Risk, Neurodegenerative Disorder Risk

    3) By Pharmacogenomic Testing: Adverse Drug Reaction Prediction, Psychiatric Medication Response, Dosage Optimization

    4) By Carrier Screening: Cystic Fibrosis Carrier Screening, Sickle Cell Anemia Carrier Screening, Tay-Sachs Carrier Screening

    How Are Industry Trends Steering The Expansion Of The Predictive Genetic Testing And Consumer Genomics Market?

    Leading corporations in the predictive genetic testing and consumer genomics market are prioritizing the creation of cutting-edge solutions like consumer genomics insight services. These services aim to furnish individuals with customized health findings and aid in the early recognition of genetic threats. Direct-to-consumer genetic tests, which don’t require a medical prescription, form the basis of consumer genomics insight service. They are used to analyze a person’s DNA, providing insights into their lineage, health risks, traits, and general wellbeing. For example, Strand Life Sciences Private Limited, a tech firm based in India, launched Strand Genomic Wellness in November 2022, offering individual-specific health findings. It lets people comprehend their genetic susceptibility to various diseases, advocating proactive health maintenance and prevention based on genomic information. The main benefit of this is it allows individuals and their doctors to make knowledgeable lifestyle and medical decisions based on unique genetic profiles.

    Which Firms Are Driving Innovation Within The Predictive Genetic Testing And Consumer Genomics Market?

    Major companies operating in the predictive genetic testing and consumer genomics market are Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, QIAGEN N.V., Ancestry.com, Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., 23andMe Inc., Helix Inc., Color Health Inc., Mapmygenome India Ltd., Reliance Life Sciences, Dante Labs Inc., EasyDNA, Gene by Gene Ltd., Nebula Genomics Inc., Pathway Genomics Corporation.

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/predictive-genetic-testing-and-consumer-genomics-global-market-report

    What Are The Emerging Regional Trends Driving The Predictive Genetic Testing And Consumer Genomics Market?

    North America was the largest region in the predictive genetic testing and consumer genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive genetic testing and consumer genomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=25884&type=smp

    Browse Through More Reports Similar to the Global Predictive Genetic Testing And Consumer Genomics Market 2025, By The Business Research Company

    Genetic Testing Services Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/genetic-testing-services-global-market-report

    Genomics Personalized Health Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/genomics-personalized-health-global-market-report

    Prenatal And Newborn Genetic Testing Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

    About The Business Research Company:

    With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Insights: Predictive Genetic Testing And Consumer Genomics Market Expected to Surpass $16.14 Billion by 2029

    Global Insights: Predictive Genetic Testing And Consumer Genomics Market Expected to Surpass $16.14 Billion by 2029

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Are the Forecasted Growth Rate and Market Size of the Predictive Genetic Testing And Consumer Genomics Market?

    The market for genetic testing and consumer genomics has seen a swift expansion in recent years. Its rapid growth is projected to continue, moving from a worth of $7.83 billion in 2024 to a value of $9.07 billion in 2025, representing a Compound Annual Growth Rate (CAGR) of 15.7%. This growth in the historical period has been driven by factors like an intensified focus on early disease diagnosis and risk evaluation, greater affordability and availability of genetic testing methods, heightened consumer curiosity in ancestry and attribute analysis, continued growth of telehealth platforms, and an increasing occurrence of chronic and inherited diseases.

    In the coming years, significant growth is anticipated in the genetic testing and consumer genomics market. It is projected to expand up to $16.14 billion by 2029 at a compound annual growth rate (CAGR) of 15.5%. The surge during the forecast period is primarily due to the rising demand for personalized healthcare and preventive medicine, an increment in the availability of direct-to-consumer genetic testing kits, growing application of genomics in clinical decision-making, increasing investments in biotechnological and genetic studies, and escalating governmental contribution for genomic research and precision medicine initiatives. Some prominent trends within this projection period include progress in next-generation sequencing, application of AI and machine learning in the interpretation of genetic data, advancements in mobile and home-testing technologies, incorporation of genetic data into electronic health records, and improvements in microarray technology.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25884&type=smp

    Which Factor Is Shaping The Future Of The Predictive Genetic Testing And Consumer Genomics Market?

    The increased consciousness regarding personalized healthcare is predicted to boost the predictive genetic testing and consumer genomics market’s expansion. Personalized healthcare is a medical practice method that tailors prevention and treatment plans based on a person’s genetic makeup, lifestyle, and environmental influences. The consciousness surrounding personalized healthcare is rising because it heightens the success rate of treatments by aligning them with a patient’s specific biological traits. Predictive genetic testing and consumer genomics contribute to personalized healthcare by uncovering genetic risks and characteristics, allowing for customized prevention, early identification, and treatment plans based on a person’s genetic composition. For example, in February 2024, the US-based Personalized Medicine Coalition, a professional membership organization, reported that the Food and Drug Administration (FDA) had given approval for 16 new personalized medicines in 2023, showing a surge from the 6 approved in 2022. Thus, the growing consciousness about personalized healthcare is spurring the advancement of the predictive genetic testing and consumer genomics market.

    What Is The Segment-Wise Breakdown Of The Predictive Genetic Testing And Consumer Genomics Market?

    The predictive genetic testing and consumer genomics market covered in this report is segmented –

    1) By Testing Type: Diagnostic Testing, Predictive Testing, Pharmacogenomic Testing, Carrier Screening

    2) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray Technology, DNA Sequencing

    3) By Service Type: Genetic Counseling Services, Sample Collection And Analysis, Data Interpretation And Reporting

    4) By Application: Breast And Ovarian Cancer, Cardiovascular Screening, Diabetic Screening And Monitoring, Colon Cancer, Parkinsonism Or Alzheimer’s Disease, Urologic Screening Or Prostate Cancer Screening, Orthopedic And Musculoskeletal, Other Cancer Screening, Other Diseases

    5) By End User: Healthcare Providers, Research Institutions, Diagnostic Laboratories, Consumers (Direct-to-Consumer Testing)

    Subsegments:

    1) By Diagnostic Testing: Cancer Diagnostic Testing, Neurological Disorder Testing, Rare Disease Diagnostics

    2) By Predictive Testing: Cancer Risk Prediction, Cardiovascular Disease Risk, Neurodegenerative Disorder Risk

    3) By Pharmacogenomic Testing: Adverse Drug Reaction Prediction, Psychiatric Medication Response, Dosage Optimization

    4) By Carrier Screening: Cystic Fibrosis Carrier Screening, Sickle Cell Anemia Carrier Screening, Tay-Sachs Carrier Screening

    What Future Market Trends Are Projected For The Predictive Genetic Testing And Consumer Genomics Industry?

    Key players in the predictive genetic testing and consumer genomics market are concentrating on developing innovative services like consumer genomics insight, aimed at providing people with personalized health insights and aiding in the early identification of genetic risks. Consumer genomics insight services are direct-to-consumer genetic examination solutions that examine an individual’s DNA to provide information on inheritance, health dangers, traits, and wellbeing without requiring a medical prescription. For example, in November 2022, an Indian tech company called Strand Life Sciences Private Limited launched Strand Genomic Wellness to deliver personalized health insights. This service helps individuals realize their genetic risks for different diseases, promoting active health management and preventive care through genomic data. The key benefit is that it empowers individuals and their healthcare providers to make informed lifestyle and medical choices based on their distinct genetic characteristics.

    Which Companies Hold The Largest Market Share In The Predictive Genetic Testing And Consumer Genomics Sector?

    Major companies operating in the predictive genetic testing and consumer genomics market are Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, QIAGEN N.V., Ancestry.com, Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., 23andMe Inc., Helix Inc., Color Health Inc., Mapmygenome India Ltd., Reliance Life Sciences, Dante Labs Inc., EasyDNA, Gene by Gene Ltd., Nebula Genomics Inc., Pathway Genomics Corporation.

    Get The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/predictive-genetic-testing-and-consumer-genomics-global-market-report

    How Does Regional Performance Compare Across The Predictive Genetic Testing And Consumer Genomics Industry?

    North America was the largest region in the predictive genetic testing and consumer genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive genetic testing and consumer genomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=25884&type=smp

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model